Why ECG device makers may stop rebuilding arrhythmia analysis from scratch

The FDA has granted 510(k) clearance to Monebo Technologies' Kinetic Software Library, an ECG analysis library that manufacturers integrate into their own devices. Monebo and its regulatory partner Innolitics announced the clearance on October 27 through Business Wire, and Diagnostic and Interventional Cardiology reported it two days later.

For companies weighing their options, arrhythmia analysis could become a sourcing decision. An engineering or regulatory lead at an ECG company can weigh writing and defending beat detection in-house against licensing it from an outside supplier. Innolitics partner J. David Giese made exactly that pitch in the announcement: a cleared starting point, so manufacturers can spend their effort on their own products rather than rebuilding arrhythmia analysis from scratch.

What a manufacturer actually integrates

The library plugs into a manufacturer's device through what Monebo calls a simple cross-platform API. The press release says it is intended for use by qualified medical professionals for assessing ECG data. Diagnostic and Interventional Cardiology's version shortens that to assessing ECG data. The longer wording, with its professional-user qualifier, is the one to read closely for any product aimed at a different kind of user.

The two companies split the work along clear lines. Monebo built and tested the software. Innolitics set the FDA regulatory strategy, guided Monebo's engineers through the software and cybersecurity documentation, and handled every interaction with the agency. George Hattub, Innolitics' senior regulatory affairs project manager, led the submission.

That pairing is a useful model for smaller software companies. An algorithm specialist with two decades of signal-processing work handled the code. A firm that does FDA software submissions for a living handled the paperwork, and the announcement names cybersecurity documentation as part of that job.

Fifty-one clearances downstream

The most telling number in the announcement concerns Monebo's past work. Its earlier FDA-cleared libraries sit at the root of a long chain of ECG devices: 51 later clearances trace their predicate lineage back to Monebo. In other words, dozens of products reached market partly by showing they were equivalent to something descended from Monebo's software.

Monebo's count of 51 suggests the same mechanism working across a whole product category rather than one product family. For a device maker shopping for an analysis engine, that lineage is a track record anyone can check in FDA records. Few vendors can say their earlier software sits at the root of that many later clearances.

How it compares and where clearance stops

Medical Design & Outsourcing reported on B-Secur's HeartKey library from Belfast, which received 510(k) clearance, announced in a February 2021 release, for signal conditioning, heart rate and arrhythmia analysis algorithms. Those algorithms cover atrial fibrillation, bradycardia and tachycardia. HeartKey can run embedded on a device, at the application layer or in the cloud, and B-Secur built it to integrate into semiconductors for medical, health monitoring and consumer wellness products.

Kinetic is sold on beat-level detail: ectopic beat detection and QRS feature extraction sit alongside heart rate and rhythm analysis, delivered through a cross-platform API. A team comparing the two would map each library's cleared functions and deployment options against its own hardware and label. That's a short, concrete checklist, and the products differ on it.

There is a fair objection to the whole cleared-component argument. A clearance is regulatory evidence. It isn't the false-alarm rate a clinician lives with. Monebo's announcement did not include accuracy figures, which suggests manufacturers weighing the library could ask for performance data directly before building it into a product.

So the clearance sets a regulatory starting line. How the library performs on a given maker's sensors and patient population is still that maker's to measure, and it decides whether the cardiologist reading the output trusts the alerts.

Next steps from Austin

Monebo is making the Kinetic Software Library available to ECG device manufacturers now and says it will keep working with Innolitics as the library grows. Neither company gave a timeline for what gets added.

The clearest signal will show up in FDA records. If new ECG device clearances start tracing their lineage to K260640, the way 51 traced to Monebo's earlier work, the library will have become part of the base that other ECG products are built on.